Trials / Unknown
UnknownNCT03980990
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- University of Saskatchewan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot randomized controlled trial aims to evaluate the feasibility for safety examination of continued metformin therapy in patients with type 2 diabetes (T2D) following invasive coronary angiography. Metformin will be continued until coronary angiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Continuation of Metformin |
Timeline
- Start date
- 2019-06-17
- Primary completion
- 2020-06-17
- Completion
- 2020-06-17
- First posted
- 2019-06-10
- Last updated
- 2019-06-20
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03980990. Inclusion in this directory is not an endorsement.